Redcare Pharmacy stock lifts on Jefferies' higher target
Published on 08/26/2026 at 11:14 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Redcare Pharmacy (NL0012044747) stock rose after Jefferies lifted its price target to 97 euro from 83 euro and kept a Buy rating on August 26, 2026. The shares closed at 62.05 euro on Xetra on August 25, 2026 and traded at 62.70 euro in the latest quoted view, while market value was listed at 1.24 billion euro.
In the same note, Jefferies said Redcare's first half beat expectations on growth, customer gains and profitability, and it also said the raised 2026 guidance still looked conservative. The move matters because the new target implies 55.57% upside from the 62.35 euro reference price used in the analysis.
Higher target, higher bar
The broker's call gives the stock a fresh valuation anchor after a run of strong operating updates this year. Jefferies' own table showed an average target of 92.00 euro, so the new 97 euro view sits above consensus and leaves the company with a wider gap to the current quote.
Redcare has already told investors in 2026 that the business is growing faster and becoming more profitable, and that backdrop is what the latest analyst note is leaning on. For shareholders, the key question is whether the improved margin path can keep pace with a share price that still sits far below the new target.
Q2 momentum still matters
Redcare said in its Q2 2026 update that revenue grew 20% and that the EBITDA margin expanded, while international operations turned profitable. The company also raised its full-year 2026 guidance after stronger-than-expected quarter-to-date trading.
Those figures give the Jefferies call a concrete basis: 20% revenue growth, a higher EBITDA margin and a revised 2026 outlook are enough to support the more constructive view. The comparison is clear - a 20% sales increase and a higher margin profile sit well above a flat-growth story.
Redcare Pharmacy product focus
The best-known consumer brand remains shop-apotheke.com, the group's online pharmacy platform for prescription and non-prescription medicines. That storefront is the core product investors watch when they track customer growth, repeat demand and basket size.
Shares and valuation
Redcare Pharmacy shares traded at 62.70 euro in the latest quoted view on August 26, 2026, against a market cap of 1.24 billion euro. The stock remained well below Jefferies' 97 euro target, a spread that keeps valuation and execution in the foreground.
Company
Company: Redcare Pharmacy N.V.
ISIN: NL0012044747
Ticker: SHPPF
Exchange: Xetra
Price (as of August 26, 2026): EUR 62.70
Market cap: EUR 1.24 billion
Sector / Industry: Health Care / Pharmaceuticals
Index membership: SDAX
